Among the ten centres selected for Covidshield testing, Mumbai’s KEM Hospital got approval on 7th August from ICMR to commence phase 2 and 3 trials of the vaccine being developed by Serum institute of India. In the first stage conducted at U.K, the clinical efficacy was proven to be safe with minimal side effects.
Dr. Hemanth, the KEM hospital dean says, the vaccine developed at Oxford university will soon be tested in a week on 160 people and 1600 people across 10 centres as part of phase 2 trials. The dean stated that state’s ethics committee clearance is due to be processed for further testing. Deshmukh told, the hospital began inviting healthy volunteers where they can accommodate 160 people from different socio-economic backgrounds in the age group of 20-50. He further added that the second and third phase will be initiated to asses the immunogenicity of the vaccine candidate.
Suresh Kakani, additional municipal health commissioner said he is glad that KEM hospital from Mumbai has been opted for testing covishield in view of their credibility and good quality health services.
The Kamakhya Devi Temple in Assam, renowned as one of the oldest and most revered…
Prashant Varma, acclaimed for his Pan-India directorial debut with “Hanuman,” is charting a bold course…
Last December, Prabhas and director Prashanth Neel made 'Salaar,' an action-packed movie that did okay…
Photos from the ‘Ramayana’ film set have recently surfaced online, sparking widespread excitement. The spotlight…
The CM of AP YS Jagan Mohan Reddy has announced his party's election manifesto for…
Vishwak Sen, a talented young actor in Telugu movies, is known for playing different kinds…